Skip to main content
Image
ucbcaresimmunology logo

UCB Logo

Stay connected, learn and inspire

By registering to our service, you will gain access to scientific data as well as access to relevant branded product information and exclusive events for healthcare professionals.

Stay tuned for more information on new product releases and events in the coming months.

Register

Request access to services exclusively for healthcare professionals active in the field of dermatology and rheumatology.

Register

If you are not a healthcare professional, click here

  • UCB Login
Forgot password?
 

You are now leaving this website

The information the reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the respective company, or via the Consumer Medicine Information or Product Information.

Continue Cancel
 
 

Register and get access to the entire content

Please register to access this content. 

By registering to our service, you will get access to non-promotional scientific data on bimekizumab as well as information and/or access to exclusive events for Health care Professionals.

Stay tuned for more information on bimekizumab and our whole immunology portfolio in the months to come!

Register Cancel
Already a member? Login here.

Logo footer

  • UCB.com
  • Meet the team
  • Privacy Policy
  • Terms & Conditions
  • Cookie Policy
  • Cookie Preferences
  • Contact Us

 

This platform is neither intended nor designed to record or report adverse events. If you have a medical enquiry, or wish to report an adverse event or product quality complaint, please contact UCB via email ucbcares.au@ucb.com or phone 03 9828 1800 (option 3).

UCB Australia Pty Ltd, ABN 48 005 799 208 Level 1, 1155 Malvern Road, Malvern, VIC 3144.
Telephone (03) 9828 1800. Facsimile (03) 9828 1860.

Last update: Fri 9 May, 2025